Ligand Pharmaceuticals
LGND
#4177
Rank
โ‚น182.21 B
Marketcap
โ‚น9,643
Share price
-0.21%
Change (1 day)
59.64%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น133.82. In 2022 the company made an earnings per share (EPS) of -โ‚น168.76 a decrease over its 2021 EPS that were of โ‚น294.91.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-175.97%
2022-โ‚น168.76-157.23%
2021โ‚น294.91-2571.43%
2020-โ‚น11.93-100.46%
2019โ‚น2,609353.48%
2018โ‚น575.331025%
2017โ‚น51.14-700%
2016-โ‚น8.52-100.87%
2015โ‚น985.311859.32%
2014โ‚น50.295.36%
2013โ‚น47.738.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.76-194.23%
2010-โ‚น44.32548.38%
2009-โ‚น6.84-98.7%
2008-โ‚น526.75-136.52%
2007โ‚น1,442-787.8%
2006-โ‚น209.68-14.58%
2005-โ‚น245.47-21.31%
2004-โ‚น311.96-55.15%
2003-โ‚น695.5181.33%
2002-โ‚น383.552.74%
2001-โ‚น373.32-45.93%
2000-โ‚น690.39-14.56%
1999-โ‚น808.02-45.52%
1998-โ‚น1,483-3.97%
1997-โ‚น1,544132.31%
1996-โ‚น664.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,206 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.68-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น298.38 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น155.27 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น158.54 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น462.76 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น338.38 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น436.40 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,201 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA